State of Alaska Department of Revenue Has $3.56 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

State of Alaska Department of Revenue raised its stake in Teleflex Incorporated (NYSE:TFX) by 386.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 25,734 shares of the medical technology company’s stock after purchasing an additional 20,439 shares during the quarter. State of Alaska Department of Revenue’s holdings in Teleflex were worth $3,556,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB increased its stake in shares of Teleflex by 103.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 100 shares during the last quarter. Headlands Technologies LLC acquired a new position in shares of Teleflex during the 4th quarter worth $29,000. Whipplewood Advisors LLC increased its stake in shares of Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock worth $32,000 after purchasing an additional 231 shares during the last quarter. True Wealth Design LLC increased its stake in shares of Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 104 shares during the last quarter. Finally, IFP Advisors Inc increased its stake in shares of Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after purchasing an additional 217 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE TFX opened at $118.03 on Friday. The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. The company has a fifty day simple moving average of $125.44 and a 200 day simple moving average of $150.14. The company has a market cap of $5.22 billion, a P/E ratio of 37.23, a P/E/G ratio of 1.84 and a beta of 1.10. Teleflex Incorporated has a 1 year low of $116.60 and a 1 year high of $249.91.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.03. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. During the same period in the prior year, the firm earned $3.21 EPS. Teleflex’s quarterly revenue was down 5.0% compared to the same quarter last year. On average, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date was Tuesday, May 20th. Teleflex’s dividend payout ratio (DPR) is presently 42.90%.

Analyst Ratings Changes

Several research analysts have recently commented on TFX shares. Royal Bank Of Canada dropped their price target on shares of Teleflex from $150.00 to $145.00 and set a “sector perform” rating on the stock in a research note on Friday, May 2nd. Raymond James Financial lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Wall Street Zen upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.